News
By Maia Hibbett, Wired | 09.09.2026
THE INSTAGRAM POST, precision-guided by sex and age, had zeroed in on its target. Yuchen Tu is a conservatory-trained viola...
By Terence Keel, Los Ángeles Review of Books | 09.06.2026
This is the 16th installment in the Legacies of Eugenics series, which features essays by leading thinkers devoted to exploring...
By Rita Rubin, USA Today | 03.06.2008
Several new companies are betting consumers will be curious enough to shell out $1,000 or more to learn what diseases...
By Amy Harmon, New York Times | 03.04.2008
On a cold day in January, Dan Stoicescu, a millionaire living in Switzerland, became the second person in the world...
By Karen Buckelew, Maryland Daily Record | 03.03.2008
Cutting the Maryland Stem Cell Research Fund by nearly 80 percent would mean "effectively stopping the program," according to the...
By Jonathan Petre, The Telegraph (UK) | 03.03.2008
The body which regulates embryo research is to come under fire for allowing scientists to create part-human, part-animal hybrids.
A...
A...
By David Hamilton, The Industry Standard | 03.03.2008
Last week, the Irvine, Calif., startup PrimeGen Biotech made a startling claim: It had successfully transformed adult skin, kidney and...
By John Lauerman, Bloomberg | 02.29.2008
A Harvard University scientist backed by Google Inc. and OrbiMed Advisors LLC plans to unlock the secrets of common diseases...
By Karen Kaplan, Los Angeles Times | 02.24.2008
Amid the tumult of the delivery room, Rohit and Geeta Jain were calm about one thing: Their new baby was...
By Amy Harmon, New York Times | 02.24.2008
Victoria Grove wanted to find out if she was destined to develop the form of emphysema that ran in her...



